InvestorsHub Logo
Followers 62
Posts 7553
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Wednesday, 11/02/2022 8:13:20 AM

Wednesday, November 02, 2022 8:13:20 AM

Post# of 426240
R and D of new drugs is a very expensive proposition....The U.S., as the richest country in the world, is the place where this can be done profitably.

When Judge Du did her thing on Amarin, a small company with one product, Amarin then became akin to the Rodney Dangerfield of Pharma...Whose complaint was always..."I get no respect".This predicament allows people like Nissen and countries like Germany to constantly crap on Amarin.

Amarin is now a quasi start up, which needs to either capture the U.S. market through marketing MND-2119, or to be sold to a BP which can do it better....Dr. Denner is the best person to explore these avenues.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News